Sichuan Hebang Biotechnology (603077.SH) issued a profit warning, expecting a 96.88% to 97.66% year-on-year decline in net profit for the fiscal year 2024.
Habio (603077.SH) announces a decrease in performance forecast for the year 2024, expecting a decrease in net profit...
Sichuan Hebang Biotechnology (603077.SH) announced a forecasted decrease in performance for the year 2024, estimating a net profit attributable to shareholders of the listed company of 30 to 40 million yuan, a year-on-year decrease of 96.88% to 97.66%.
Related Articles
US Stock Market Move | Autodesk, Inc. (ADSK.US) rebounds more than 5% after falling nearly 11% in the previous three trading days.
US Stock Market Move | Quantum computing sector rose, Quantum Computing (QUBT.US) surged over 5%
US Stock Market Move | Sonnet BioTherapeutic (SONN.US) soared by over 110%, with stock prices nearly increasing 8 times within the month.
US Stock Market Move | Autodesk, Inc. (ADSK.US) rebounds more than 5% after falling nearly 11% in the previous three trading days.
US Stock Market Move | Quantum computing sector rose, Quantum Computing (QUBT.US) surged over 5%
US Stock Market Move | Sonnet BioTherapeutic (SONN.US) soared by over 110%, with stock prices nearly increasing 8 times within the month.
RECOMMEND
Rare Sales Decline for Tank Brand—How Will Great Wall Motor Defend Its Market Position?
14/07/2025
Inside the Explosive Growth of the New Tea Beverage Sector: Supply Chains, Innovation, and Cultural Capital
14/07/2025
Hafu Securities Joins the Race as Hong Kong Accelerates Its Push to Become a Virtual Asset Hub
14/07/2025
